COLLABORATIVE INNOVATION

Seeding tomorrow’s priority medicines
Our resources
your results

Drug target & assays
Helping you

to create new medicines

Concept
Our expertise
your creativity

Results

European Lead Factory

Latest news

16 March 2020

Phenotypic Screening now offered by the European Lead Factory

16 March 2020

UK researchers remain eligible to apply for ELF screening post-Brexit

29 January 2020

ELF highlighted in IMI publication on 10 years of public private partnerships

Call for proposals

Find out how you can boost your drug discovery programme and submit your screening proposal today

Publications

14 January 2020

Identification of A Novel Class of Benzofuran Oxoacetic Acid-Derived Ligands that Selectively Activate Cellular EPAC1.

14 January 2020

Synthesis and Structure‐Activity Relationships of N‐(4‐Benzamidino)‐Oxazolidinones: Potent and Selective Inhibitors of Kallikrein‐Related Peptidase 6

View all publications

European Lead Factory

Hitting the targets

The video report from the European
Lead Factory (ELF) Stakeholder
Meeting, 25-26 April, 2017 with an exciting agenda focussing on four
years of successful collaboration, the impact of the European Lead Factory
and the future of drug discovery.
View all animations

Events

23 March 2020

BioEurope Spring Conference on 23-25 March in Paris, France

View all events

Testimonials

Dirk Finsinger

Merck

https://europeanleadfactory.eu/results/testimonials

Christopher Schofield, PhD

Head of Organic Chemistry, University of Oxford

Testimonial Chris

Freek Janssen, PhD

Leiden Institute of Chemistry Molecular Physiology Leiden University

https://europeanleadfactory.eu/results/testimonials#FreekJanssen

Tweets by EULeadFactory

http://www.merckgroup.com/en/index.html

http://www.janssen.com/

http://www.astrazeneca.com

http://www.bayerpharma.com

http://www.lundbeck.com

http://en.sanofi.com/

http://www.ucb.com

http://www.tarosdiscovery.com

http://www.edelris.com

http://www.sygnaturediscovery.com

http://www.mercachemsyncom.com

http://www.arttic.eu/pages/en/home.php

http://www.lygature.org

http://www.bioascent.com

http://www.chemaxon.com

http://www.lead-discovery.de

http://www.pivotparkscreeningcentre.com

http://www.lifesci.dundee.ac.uk

http://www.leiden.edu

http://www.lumc.nl

http://www.mpi-dortmund.mpg.de

http://www.ru.nl/imm/

http://www.drugdesign.nl

http://www.dtu.dk

http://www.uni-due.de/en/

http://www.asn.leeds.ac.uk

http://www.nottingham.ac.uk/chemistry

http://www.ox.ac.uk

http://www.chem.vu.nl/en/index.asp

https://www.mmv.org/

https://www.grunenthal.com/

http://www.servier.com

© European Lead Factory and its partners.

The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n' 115489, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7 / 2007-2013) and EFPIA companies' in kind contribution.

This project has also received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806948: ‘ESCulab: European Screening Centre; Unique Library for Attractive Biology’. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Medicines for Malaria Venture (MMV).